Josianne Nitcheu

Perforin-Dependent Brain-Infiltrating Cytotoxic CD8+ T Lymphocytes Mediate Experimental Cerebral Malaria Pathogenesis

Josianne Nitcheu, Olivia Bonduelle, Christophe Combadière et al. · The Journal of Immunology · 2003 · 281 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension

Séverine Vermeire, Bruce E. Sands, Herbert Tilg et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 64 citations

Medicine, Clinical Sciences, Pharmacology +14

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen–Negative Patients

Christoph Höner zu Siederdissen, Aric J. Hui, Wattana Sukeepaisarnjaroen et al. · The Journal of Infectious Diseases · 2018 · 57 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Therapeutic vaccination of chronic hepatitis B patients with ABX203 (NASVAC) to prevent relapse after stopping NUCs: contrasting timing rebound between tenofovir and entecavir

Heiner Wedemeyer, Aric J. Hui, Wattana Sukeepaisarnjaroen et al. · Journal of Hepatology · 2017 · 13 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

OP21 ABX464 is safe and efficacious in a proof-of-concept study in ulcerative colitis patients

Séverine Vermeire, Xavier Hébuterne, Piotr Napora et al. · Journal of Crohn s and Colitis · 2019 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17